Success Metrics

Clinical Success Rate
82.4%

Based on 14 completed trials

Completion Rate
82%(14/17)
Active Trials
0(0%)
Results Posted
36%(5 trials)
Terminated
3(12%)

Phase Distribution

Ph early_phase_1
2
8%
Ph not_applicable
8
32%
Ph phase_3
4
16%
Ph phase_1
2
8%
Ph phase_2
3
12%
Ph phase_4
6
24%

Phase Distribution

4

Early Stage

3

Mid Stage

10

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
2(8.0%)
Phase 1Safety & dosage
2(8.0%)
Phase 2Efficacy & side effects
3(12.0%)
Phase 3Large-scale testing
4(16.0%)
Phase 4Post-market surveillance
6(24.0%)
N/ANon-phased studies
8(32.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

77.8%

14 of 18 finished

Non-Completion Rate

22.2%

4 ended early

Currently Active

0

trials recruiting

Total Trials

25

all time

Status Distribution
Active(2)
Completed(14)
Terminated(4)
Other(5)

Detailed Status

Completed14
unknown5
Terminated3
Not yet recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
0
Success Rate
82.4%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (8.0%)
Phase 12 (8.0%)
Phase 23 (12.0%)
Phase 34 (16.0%)
Phase 46 (24.0%)
N/A8 (32.0%)

Trials by Status

completed1456%
not_yet_recruiting28%
terminated312%
unknown520%
withdrawn14%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT07246629Phase 4

Lumbar Drain With Intrathecal Nicardipine in Aneurysmal Subarachnoid Hemorrhage

Not Yet Recruiting
NCT06093893Phase 4

Hypotensive Anesthesia for Orthognathic Surgery

Completed
NCT07364201Not Applicable

A Comparison of Nicardipine and Labetalol for Blood Pressure Control in Intensive Care Patients After Hemorrhagic Stroke Brain Surgery

Completed
NCT07044232Phase 4

NICardipine for Fast Achievement of Systolic BP Targets in ICH

Not Yet Recruiting
NCT01996436Phase 4

The Intra-arterial Vasospasm Trial

Terminated
NCT05625503Early Phase 1

Dilution of Verapamil During Intraarterial Administration

Completed
NCT03184155Early Phase 1

Prevention of Coronary Microvascular Dysfunction Post-PCI by Intracoronary Nicardipine

Withdrawn
NCT06130527Not Applicable

Comparison of the Effects of Nicardipine and Remifentanil on Surgical Visual Field

Unknown
NCT04116112Phase 2

Blood Pressure After Endovascular Stroke Therapy-II

Completed
NCT04269408Phase 2

A Safety and Efficacy Study of NicaPlant® in Aneurysmal Subarachnoid Haemorrhage Patients Undergoing Aneurysm Clipping

Completed
NCT05920538Not Applicable

Effects of Subcutaneously Infiltrated Nicardipine on the Success Rate of Radial Artety Cannulation

Unknown
NCT05586347Not Applicable

Relationship Between Perioperative Carotid Blood Flow Monitoring and Cerebral Function Protection in Cardiac Surgery

Completed
NCT04538534Phase 3

Nicardipine to Avoid Spasm in Trans Radial Percutaneous Coronary Intervention

Completed
NCT03497351Not Applicable

Effects of Different Kinds of Hypotensive Drugs on Dynamic Hemodynamic Changing in Patients Under Surgeries

Completed
NCT02558023Phase 3

The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine

Terminated
NCT00415610Phase 1

Antihypertensive Treatment in Acute Cerebral Hemorrhage

Completed
NCT02271191Phase 4

Effect of Nicardipine on Renal Function in Deliberate Hypotension

Completed
NCT01951950Phase 1

Nicardipine vs Esmolol Craniotomy Emergence

Completed
NCT00508118Phase 2

NICardipine Neuroprotection in AortiC Surgery (NICNACS)

Terminated
NCT00093925Phase 3

Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
25